THOMPSON DAVIS & CO., INC. - RXI PHARMACEUTICALS CORP NEW ownership

RXI PHARMACEUTICALS CORP NEW's ticker is RXII and the CUSIP is 74979C303. A total of 26 filers reported holding RXI PHARMACEUTICALS CORP NEW in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
THOMPSON DAVIS & CO., INC. ownership history of RXI PHARMACEUTICALS CORP NEW
ValueSharesWeighting
Q2 2014$9,00000.01%
Other shareholders

There were no reported owners of RXI PHARMACEUTICALS CORP NEW in Q3 2014.

NameSharesValueWeighting ↓
View complete list of RXI PHARMACEUTICALS CORP NEW shareholders